lung
ATS issues report on emerging issues in HIV-associated pulmonary disease
The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus (HIV)-associated pulmonary disease. The report examines the evolving landscape of HIV and its associated diseas…
Blood protein in lung cancer could improve diagnosis and treatment
Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease — difficult to diagnose in its earliest and most treatable stages — and to develop drugs that stop lung cancer fr…
Study links vitamin D to lung cancer survival
ANN ARBOR, Mich. — Recent research suggests vitamin D may be able to stop or prevent cancer. Now, a new study finds an enzyme that plays a role in metabolizing vitamin D can predict lung cancer survival.
The study, from researchers at the U…
Lymph node dissection is not essential in small screen-detected lung cancers, new research shows
Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases , according to a study published in the March issue of the Journal of Thoracic…
Spontaneous smoking cessation may be an early symptom of lung cancer, research suggests
Many longtime smokers quit spontaneously with little effort shortly before their lung cancer is diagnosed, leading some researchers to speculate that sudden cessation may be a symptom of lung cancer.
Most patients who quit did so before noticing a…
Radio-guided surgery a safe and simple way to remove potentially cancerous nodules in the lung
Using tiny spheres of radioactive liquid to guide surgeons as they remove potentially cancerous material in the lungs is safe and more effective than other techniques, Italian researchers report at the European Multidisciplinary Conference in Thorac…
Erlotinib effective and with fewer side-effects after first-line treatment
The targeted cancer drug erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient’s cancer has progressed quickly after treatment with first-line therapy, the results of a new phase III trial…
New study finds molecular mechanisms that control Rb2/p130 gene expression in lung cancer
Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.
In a new study, researchers from the Sba…
Quick, easy test identifies aggressive type of lung cancer in never-smokers
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Dr P…
Bone drug zoledronic acid may help prevent spread of early lung cancer
A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.
Dr Michela Qui…
Pulmonary fibrosis inhibited by pentraxin-2/SAP in research study
MALVERN, PA — February 10, 2011 — Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Jour…
